Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
September 18, 2024 10:00 ET
|
Biognosys AG
Biognosys Enters Reselling Agreement for Spectronaut® Proteomics Software with Leading Provider of Mass Spectrometry Systems
Europe Protein Expression Market Research 2024: Increasing Demand for Protein Biologics Creating the Need for Protein Expression - Forecasts to 2033
August 22, 2024 10:09 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Europe Protein Expression Market: Focus on Application, End User, Product, Expression System, and Country - Analysis and Forecast, 2023-2033" report...
Protein Crystallization Market Report 2024: Trends, Forecast and Competitive Analysis to 2030 - A $1.6 Billion Industry Driven by Advances in Protein Crystallography Techniques
August 22, 2024 04:01 ET
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Protein Crystallization Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
PATH LAWSUIT UPDATE: UiPath, Inc. (NYSE:PATH) Shareholders are Reminded of Upcoming Deadline in Securities Fraud Action Filed by BFA Law; Contact Us if you Suffered Losses
July 22, 2024 06:35 ET
|
Bleichmar Fonti & Auld
UiPath, Inc. investors that lost money in their investment are encouraged to contact BFA Law before August 19, 2024 Legal deadline.
TDC SHAREHOLDER NOTICE: Teradata Corp. (NYSE:TDC) Investors that Lost Money are Encouraged to Contact BFA Law about Approaching Securities Fraud Legal Deadline
July 18, 2024 07:31 ET
|
Bleichmar Fonti & Auld
Teradata Corp. investors that Lost Money in their investment are encouraged to contact BFA Law before the August 13, 2024 Legal deadline.
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
July 03, 2024 08:00 ET
|
Olink Proteomics AB
Inaugural network of Olink® Certified Service Providers includes eading contract research organizations (CROs) and service labs around the world.
Protein Engineering Industry to Cross $7.8 Billion by 2030 - Discover the Key Trends, Drivers, and Market Players Shaping the Future Landscape
June 19, 2024 04:07 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Protein Engineering - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Protein...
Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis
June 18, 2024 07:00 ET
|
Chemomab Therapeutics
New publication confirms the role of CCL24 in primary sclerosing cholangitis and the potential of CM-101 to impact PSC disease progression and severity.
Global Protein Expression Market Report 2024-2032
June 12, 2024 10:51 ET
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Protein Expression Market Report by Product, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference
June 06, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab presents new data supporting clinical potential of CM-101 as novel treatment for PSC at EASL 2024 and Gordon Research Conference